Lazowski L E, Miller F G, Boye M W, Miller G A
SASSI Institute, Bloomington, IN 47407-5069, USA.
J Pers Assess. 1998 Aug;71(1):114-28. doi: 10.1207/s15327752jpa7101_8.
This article presents analyses on psychometric properties of a recent revision of the Substance Abuse Subtle Screening Inventory (SASSI-3). Participants were 772 individuals from a range of clinical settings who were independently diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders (3rd ed., rev. [DSM-III-R]; American Psychiatric Association [APA], 1987) or DSM-IV (APA, 1994) criteria regarding the presence or absence of a substance-dependence disorder. A development sample (n = 391) was used to formulate SASSI-3 decision rules that yielded 95% agreement with clinical diagnoses of substance dependence. Correspondence with the criterion variable was shown to be 97% in a cross-validation sample (n = 381) from the same clinical settings. Convergent relations were demonstrated with a variety of other indexes of substance misuse, including clinical assessments of substance abuse history, alcohol and drug-related arrests, self-reported use of illicit drugs, and other instruments designed to screen for substance misuse. Further, logistic regression analyses indicated no significant differences in the overall accuracy of the SASSI-3 as a function of respondents' demographic characteristics or clinical ratings of respondents' level of adjustment and functioning (Global Assessment of Functioning ratings; APA, 1987, 1994).
本文介绍了对药物滥用隐蔽筛查量表(SASSI-3)最新修订版心理测量特性的分析。参与者为772名来自一系列临床环境的个体,他们根据《精神疾病诊断与统计手册》(第3版,修订版[DSM-III-R];美国精神病学协会[APA],1987年)或DSM-IV(APA,1994年)关于是否存在药物依赖障碍的标准进行独立诊断。一个开发样本(n = 391)用于制定SASSI-3决策规则,该规则与药物依赖的临床诊断达成了95%的一致率。在来自相同临床环境的交叉验证样本(n = 381)中,与标准变量的符合率为97%。该量表与各种其他药物滥用指标显示出收敛关系,包括药物滥用史的临床评估、与酒精和药物相关的逮捕记录、自我报告的非法药物使用情况,以及其他旨在筛查药物滥用的工具。此外,逻辑回归分析表明,SASSI-3的总体准确性在受访者的人口统计学特征或受访者调整和功能水平的临床评分(功能总体评估评分;APA,1987年,1994年)方面没有显著差异。